Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 146 users online. 0 members and 146 guests.

Most users ever online was 3,930 at 06:07 PM on 04-20-2019.

1 result in 0.0053 seconds.
Keywords
Members
Tags
Expedites x
  •  

  • U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19

    U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19 | site |




    (March 30, 2020) - - Today (March 30, 2020), the U.S. Food and Drug Administration (FDA) published the following information:



    March 30, 2020

    Statement From:

    Commissioner of Food and Drugs - Food and Drug Administration

    Stephen M. Hahn M.D.

    The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic. Every action the FDA has taken during this public health emergency to address the COVID-19 pandemic has balanced the urgent need to make diagnostic tests available with providing a level of oversight that ensures accurate tests are being deployed. Moreover, as in previous...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19
    by Staff Reporter 1
    U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19 | site |




    (March 30, 2020) - - Today (March 30, 2020), the U.S. Food and Drug Administration (FDA) published the following information:



    March 30, 2020

    Statement From:

    Commissioner of Food and Drugs - Food and Drug Administration

    Stephen M. Hahn M.D.

    The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic. Every action the FDA has taken during this public health emergency to address the COVID-19 pandemic has balanced the urgent need to make diagnostic tests available with providing a level of oversight that ensures accurate tests are being deployed. Moreover, as in previous...
    04-01-2020, 02:20 AM

Menu

Collapse

Menu

Collapse

Working...
X